The Parkinson’s Disease Therapeutics Pipeline Program, hosted by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), is a funding opportunity designed to advance promising Parkinson’s disease therapeutics through pre-clinical and early clinical development. The program supports pharmacological and non-pharmacological interventions with strong biological rationale and clear translational potential to prevent, slow, or reduce symptoms of Parkinson’s disease.

It is open to industry applicants and academia–industry partnerships worldwide that are developing differentiated therapeutic approaches with a viable path toward the clinic.

Pre-proposals must be submitted by the deadline and are reviewed on a rolling basis; selected applicants are invited to submit a full proposal through scheduled review cycles. The next application deadline is February 22, 2026. To learn more visit the webpage, here.